BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27793567)

  • 1.
    Jain A; Mathur A; Pandey U; Sarma HD; Dash A
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5785-5791. PubMed ID: 27793567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of 68Ga-labeled fatty acids for their potential use in cardiac metabolic imaging.
    Jindal A; Mathur A; Pandey U; Sarma HD; Chaudhari P; Dash A
    J Labelled Comp Radiopharm; 2014 Jun; 57(7):463-9. PubMed ID: 24966158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
    Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
    Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of novel gallium-68 labeled rhodamine: A potential PET myocardial perfusion agent.
    Jammaz IA; Al-Otaibi B; Al-Hokbani N; Okarvi SM
    Appl Radiat Isot; 2019 Feb; 144():29-33. PubMed ID: 30508730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
    Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
    J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of
    Jain A; Mathur A; Pandey U; Sarma HD; Dash A
    Appl Radiat Isot; 2018 Oct; 140():35-40. PubMed ID: 29936274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
    Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
    Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of α
    Grönman M; Tarkia M; Kiviniemi T; Halonen P; Kuivanen A; Savunen T; Tolvanen T; Teuho J; Käkelä M; Metsälä O; Pietilä M; Saukko P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    J Transl Med; 2017 Jun; 15(1):144. PubMed ID: 28629432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics.
    Kumar P; Tripathi SK; Chen CP; Wickstrom E; Thakur ML
    Mol Imaging Biol; 2019 Feb; 21(1):130-139. PubMed ID: 29802552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward realization of 'mix-and-use' approach in ⁶⁸Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of ⁶⁸Ga-labeled NODAGA-coupled RGD peptide derivative.
    Chakraborty S; Chakravarty R; Vatsa R; Bhusari P; Sarma HD; Shukla J; Mittal BR; Dash A
    Nucl Med Biol; 2016 Jan; 43(1):116-123. PubMed ID: 26527030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
    Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
    Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Mittal S; Sharma R; Mallia MB; Sarma HD
    Nucl Med Biol; 2021; 96-97():61-67. PubMed ID: 33838524
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Vats K; Sharma R; Sarma HD; Satpati D; Dash A
    Anticancer Agents Med Chem; 2018; 18(9):1289-1294. PubMed ID: 29546835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of
    Dahlsson Leitao C; Rinne SS; Mitran B; Vorobyeva A; Andersson KG; Tolmachev V; Ståhl S; Löfblom J; Orlova A
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeling and Preliminary Evaluation of Ga-68 Labeled NODAGA-Ubiquicidin Fragments for Prospective Infection Imaging.
    Bhatt J; Mukherjee A; Korde A; Kumar M; Sarma HD; Dash A
    Mol Imaging Biol; 2017 Feb; 19(1):59-67. PubMed ID: 27406090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
    Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC
    J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In.
    Roosenburg S; Laverman P; Joosten L; Cooper MS; Kolenc-Peitl PK; Foster JM; Hudson C; Leyton J; Burnet J; Oyen WJ; Blower PJ; Mather SJ; Boerman OC; Sosabowski JK
    Mol Pharm; 2014 Nov; 11(11):3930-7. PubMed ID: 24992368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators.
    Chakravarty R; Chakraborty S; Dash A; Pillai MR
    Nucl Med Biol; 2013 Feb; 40(2):197-205. PubMed ID: 23218795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, Characterization, and Radiolabeling of [
    Ashhar Z; Yusof NA; Ahmad Saad FF; Mohd Nor SM; Mohammad F; Bahrin Wan Kamal WH; Hassan MH; Ahmad Hassali H; Al-Lohedan HA
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32526838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.